Literature DB >> 33924846

Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with Glycemic Variability in Patients with Type 2 Diabetes: A Cross-Sectional Study.

Fuyuko Takahashi1, Yoshitaka Hashimoto1, Ayumi Kaji1, Ryosuke Sakai1, Akane Miki1, Takuro Okamura1, Noriyuki Kitagawa1,2, Hiroshi Okada1,3, Naoko Nakanishi1, Saori Majima1, Takafumi Senmaru1, Emi Ushigome1, Masahide Hamaguchi1, Mai Asano1, Masahiro Yamazaki1, Michiaki Fukui1.   

Abstract

Glycemic control, including glycemic variability, is important for the prevention of diabetic vascular complications in patients with type 2 diabetes mellitus (T2DM). There was an association between miso soup intake and insulin resistance. However, the relationship between habitual miso consumption and glycemic control, including glycemic variability, in patients with T2DM remains unknown. We defined people without habitual miso consumption if they did not consume miso soup at all in a day. The average, standard deviation (SD), and coefficient of variation (CV), calculated as CV = (SD/average HbA1c) × 100 (%), of hemoglobin (Hb) A1c levels were evaluated. The proportions of habitual miso consumption of male and female were 88.1% and 82.3%, respectively. The average (7.0 [6.4-7.5] vs. 7.3 [6.8-8.4] %, p = 0.009), SD (0.21 [0.12-0.32] vs. 0.37 [0.20-0.72], p = 0.004), and CV (0.03 [0.02-0.04] vs. 0.05 [0.03-0.09], p = 0.005) of HbA1c levels in female with habitual miso consumption were lower than those of female without. Moreover, habitual miso consumption correlated with average (β = -0.251, p = 0.009), SD (β = -0.175, p = 0.016), and CV (β = -0.185, p = 0.022) of HbA1c levels after adjusting for covariates. However, no association between habitual miso consumption and any glycemic parameters was shown among male. This study clarified the association between habitual miso consumption and good glycemic control, including glycemic variability, in female, but not in male.

Entities:  

Keywords:  fermented soy foods; glycemic control; glycemic variability; miso; type 2 diabetes

Year:  2021        PMID: 33924846     DOI: 10.3390/nu13051488

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  35 in total

1.  Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice.

Authors:  Jian Wu; Xinxiang Wang; Hiroshige Chiba; Mitsuru Higuchi; Teruyo Nakatani; Osamu Ezaki; Hongbin Cui; Kazuhiko Yamada; Yoshiko Ishimi
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

2.  Japanese traditional miso soup attenuates salt-induced hypertension and its organ damage in Dahl salt-sensitive rats.

Authors:  Mariko Yoshinaga; Natsuko Toda; Yuki Tamura; Shouko Terakado; Mai Ueno; Kie Otsuka; Atsushi Numabe; Yukari Kawabata; Yoshio Uehara
Journal:  Nutrition       Date:  2012-01-20       Impact factor: 4.008

3.  Late-night-dinner is associated with poor glycemic control in people with type 2 diabetes: The KAMOGAWA-DM cohort study.

Authors:  Ryosuke Sakai; Yoshitaka Hashimoto; Emi Ushigome; Akane Miki; Takuro Okamura; Masako Matsugasumi; Takuya Fukuda; Saori Majima; Shinobu Matsumoto; Takafumi Senmaru; Masahide Hamaguchi; Muhei Tanaka; Mai Asano; Masahiro Yamazaki; Yohei Oda; Michiaki Fukui
Journal:  Endocr J       Date:  2018-01-27       Impact factor: 2.349

4.  Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean beta-conglycinin.

Authors:  Mitsutaka Kohno; Motohiko Hirotsuka; Makoto Kito; Yuji Matsuzawa
Journal:  J Atheroscler Thromb       Date:  2006-10       Impact factor: 4.928

5.  Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat.

Authors:  Jeremy Davis; Allan Higginbotham; Timothy O'Connor; Naima Moustaid-Moussa; Adam Tebbe; Young-Cheul Kim; Kae Won Cho; Neil Shay; Stuart Adler; Richard Peterson; William Banz
Journal:  Ann Nutr Metab       Date:  2007-03-14       Impact factor: 3.374

6.  Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.

Authors:  Yoichiro Hirakawa; Hisatomi Arima; Sophia Zoungas; Toshiharu Ninomiya; Mark Cooper; Pavel Hamet; Giuseppe Mancia; Neil Poulter; Stephen Harrap; Mark Woodward; John Chalmers
Journal:  Diabetes Care       Date:  2014-05-08       Impact factor: 19.112

7.  Estimating ideal body weight--a new formula.

Authors:  Harry J M Lemmens; Jay B Brodsky; Donald P Bernstein
Journal:  Obes Surg       Date:  2005-08       Impact factor: 4.129

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with a Low Prevalence of Sarcopenia in Patients with Type 2 Diabetes: A Cross-Sectional Study.

Authors:  Fuyuko Takahashi; Yoshitaka Hashimoto; Ayumi Kaji; Ryosuke Sakai; Yuka Kawate; Takuro Okamura; Noriyuki Kitagawa; Hiroshi Okada; Naoko Nakanishi; Saori Majima; Takafumi Senmaru; Emi Ushigome; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Nutrients       Date:  2020-12-28       Impact factor: 5.717

Review 10.  Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.

Authors:  Catherine Gorst; Chun Shing Kwok; Saadia Aslam; Iain Buchan; Evangelos Kontopantelis; Phyo K Myint; Grant Heatlie; Yoon Loke; Martin K Rutter; Mamas A Mamas
Journal:  Diabetes Care       Date:  2015-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.